FDA approves Eylea to treat all stages of diabetic retinopathy

Currently used to treat diabetic macular edema, Eylea recently gained FDA approval for treating all stages of diabetic retinopathy. Eylea works as a “vascular endothelial growth factor (VEGF)” inhibitor by stopping the growth of abnormal blood vessels in the eye. It also reduces swelling and leakage, which are what lead to vision loss. Clinical trials […]

Google makes diabetic retinopathy diagnosis easier

Google is pairing up with it’s sister company, Verily, to make screening for diabetic retinopathy and diabetic edema more accessible for patients in India. India faces a shortage of more than 100,000 eye doctors and an epidemic of diabetic retinopathy. The technology utilizes algorithms to detect the eye diseases in medical imaging and was recently […]

Lipid found in eye may help prevent diabetic retinopathy

Lipids have a bad reputation when it comes to heart disease and high cholesterol, but there is one lipid found in the eye that can actually help prevent diabetic retinopathy. This good lipid is produced by an enzyme known as ELOVL4. Recent study results concerning this enzyme and the lipids were published in the journal […]

New device approved by FDA to detect diabetic retinopathy

A new medical device that uses artificial intelligence to detect diabetic retinopathy in adults has been approved by the Food and Drug Administration (FDA). The new device will provide adults with an early diagnostic tool. The software program is known as IDx-DR and it uses an artificial intelligence (AI) algorithm to analyze images of the […]

Taking a look at diabetic retinopathy

Diabetics can develop an eye disease known as diabetic retinopathy, which is caused by damage to blood vessels in the retina due to high blood sugar. The damaged blood vessels either swell and leak or they close up preventing blood from passing through. In some case, abnormal blood vessels grown on the retina. Any of […]

FDA approves glucose monitoring system

The Food and Drug Administration recently approved the FreeStyle Libre Flash Glucose Monitoring System to be sold in the United States. The Libre is manufactured by Abbott and is currently only available overseas. The system allows patients to view blood sugar every minute of the day without pricking a finger. The device will be available […]

#1 Cause of Vision Loss in Adults? Diabetes.

Diabetic retinopathy is the #1 cause of vision loss among working adults between the ages of 20 and 74 in the United States.* Lucentis recently gained FDA approval for monthly treatment of every form of diabetic retinopathy. This marks the first drug that the FDA has approved to treat diabetic retinopathy “with or without diabetic macular […]

App allows users to ‘see’ retinal disease

A new virtual and augmented reality app called “In My Eyes” allows users to experience what it is like to have different kinds of retinal disease. Regeneron Pharmaceuticals teamed with Intouch Solutions to create the app. Available for free download in the iTunes and Google app stores, the app can be used with or without […]

Diabetics more likely to skip eye exams

Despite having a higher risk of developing serious eye diseases that could potentially rob them of their vision, nearly 60 percent of diabetics do not have yearly eye exams. Diabetics are at a greater risk of losing their vision to diabetic retinopathy and the disease can lead to additional blinding eye problems if not caught early and […]

Eylea effective for Diabetic Retinopathy

A two-year clinical trial has found that diabetic patients suffering from severe vision loss from diabetic macular edema benefit the most from receiving treatment with Eylea versus Avastin or Lucentis. Eylea was just approved for use by the FDA for treating diabetic macular edema patients last year. The study was conducted by the National Institutes […]